Cases of high blood pressure in UK children have doubled, driven by obesity and poor diet. This 'silent killer' shows no early symptoms but can cause permanent damage. Learn the signs and how parents can act.
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
New research reveals how high-fat diets can trigger molecular changes that promote liver cancer, even before tumors form. Learn how diet impacts your liver health.
Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.
Discover how daily treats and scraps cause dog obesity. Learn which breeds like Pugs & Labradors are prone and how to manage your pet's weight effectively.
A look at 2025's healthcare milestones: new obesity guidelines, Alzheimer's blood tests, gene editing breakthroughs, and India's push for affordable medicines and school sugar boards.
Explore how 2025's weight-loss drug boom in India shifted focus from fitness to thinness, raising concerns about medicalisation, side effects, and societal pressure. Read the full analysis.
Aamir Khan's daughter Ira Khan candidly discusses her battle with obesity and body image issues since 2020, revealing it feels more exposing than talking about depression. Read her powerful story.
A new study reveals over 75% of US adults may have obesity under new waist-based criteria, nearly double the BMI estimate. Researchers urge updated screening methods.
Childhood obesity in India has skyrocketed, with a 288% increase among boys. WHO warns 188 million kids globally will be obese by 2025. Learn the causes, health risks, and prevention strategies.
Dr. Mansafa Bepari sparks debate, arguing outdated parental nutrition advice contributes to obesity & diabetes in young Indians. Learn why context matters.
Celebrity nutritionist Pooja Makhija shares a simple rope technique to check waist-to-height ratio, a key indicator of metabolic risk often missed by BMI, especially for Indians.
A leading heart surgeon reveals how your social circle impacts your body weight, citing a study that shows a 57% increased obesity risk. Learn how to protect your health.
A groundbreaking study reveals the SCoR2 enzyme controls fat storage. Blocking it prevented weight gain & improved cholesterol in animal studies, opening new paths for metabolic health treatments.
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
Following CBSE's mandate for Sugar Boards, experts call for Salt Boards in state schools to combat rising lifestyle diseases among children. Learn why urgent intervention is needed.
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Scientists develop novel experimental drugs for obesity by targeting mitochondrial energy production in cells, offering a potential new treatment pathway. Learn about this breakthrough research.
A new German study reveals belly fat silently alters heart structure, raising heart disease risk, especially in men. A cardiologist explains why waist size, not just weight, is critical for Indians.
A 14-year-old from Surat needed a liver transplant due to advanced fatty liver disease, accelerated by junk food and genetic risk. Hepatologists urge urgent action on childhood obesity and diet.
ICMR study reveals disrupted sleep, chronic stress, and central obesity are key drivers of India's rising breast cancer burden, projected to add 50,000 cases yearly. Learn the risk factors.
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
India is actively reshaping its trade policy with new FTAs. Explore the signed deals, ongoing talks, and the strategic impact on exports and the economy. Read more.
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
A new study from Serbia finds most parents fail to recognise when their child is overweight, delaying crucial health interventions. Learn how to spot the signs and take action for your child's long-term wellbeing.
A new World Obesity Atlas warns 51% of the world will be overweight by 2035. Experts highlight higher cardiovascular risk for Asians at lower BMI. Learn about new drugs and safe weight management.
Discover how black cumin (kalonji), a staple in Indian kitchens, is backed by science for improving cholesterol, reducing fat cells, and supporting metabolic health. Learn easy ways to include it in your diet.